Simvastatin
Drug Category | Drug | IHD Dosing | Administration Timing Around HD Session |
---|---|---|---|
Statins | Simvastatin | 10-40mg PO Q24H | Administer Anytime During HD |
Molecular Weight (Da) | Excreted Unchanged (%) | Normal Half-Life (Hours) | ESRD Half-Life (Hours) | Plasma Protein Binding (%) | Volume of Distribution (L/kg) | Dialytic Plasma Clearance (ml/min) | % Dialyzed |
---|---|---|---|---|---|---|---|
419 | <0.5 | 2 | N/A | 95 | N/A | N/A | Minimal (N/A) |
References:
- Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug Prescribing in Renal Failure. Philadelphia: American College of Physicians;2007.
- DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB00641
- Nishikawa O, Mune M, Miyano M et al. Effect of simvastatin on the lipid profile of hemodialysis patients. Kidney International. 1999;56(Suppl 71):S219-221.